Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.


Richard Hamman to HLA-DR Antigens

This is a "connection" page, showing publications Richard Hamman has written about HLA-DR Antigens.

Connection Strength
  1. Cruickshanks KJ, Jobim LF, Lawler-Heavner J, Neville TG, Gay EC, Chase HP, Klingensmith G, Todd JA, Hamman RF. Ethnic differences in human leukocyte antigen markers of susceptibility to IDDM. Diabetes Care. 1994 Feb; 17(2):132-7.
    View in: PubMed
    Score: 0.031
  2. Kostraba JN, Cruickshanks KJ, Neville TG, Lawler-Heavner J, Chase HP, Klingensmith GJ, Gay EC, Hamman RF. Clinical characteristics of IDDM in Hispanics and non-Hispanic whites. Little evidence of heterogeneity by ethnicity. Diabetes Care. 1992 Oct; 15(10):1303-9.
    View in: PubMed
    Score: 0.029
  3. Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith GJ, Rewers M, Dabelea D. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care. 2008 Jul; 31(7):1392-6.
    View in: PubMed
    Score: 0.021
  4. Rewers M, Norris JM, Eisenbarth GS, Erlich HA, Beaty B, Klingensmith G, Hoffman M, Yu L, Bugawan TL, Blair A, Hamman RF, Groshek M, McDuffie RS. Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY). J Autoimmun. 1996 Jun; 9(3):405-10.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)